Type 2 Diabetes Mellitus and < em > Helicobacter pylori < /em > Eradication in a Clinical Population

CONCLUSIONS: H. pylori eradication rates do not differ by T2DM status, providing support for clinical trials of H. pylori eradication to reduce GC incidence among high-risk populations in the United States, such as individuals with T2DM.PMID:38569609 | PMC:PMC10997161 | DOI:10.14423/SMJ.0000000000001672

Source: Southern Medical Journal - April 3, 2024 Category: General Medicine Authors: Grace Sekaya Frances Wang HannahSofia Brown Priya Alagesan Bryan C Batch Katherine S Garman Meira Epplein Source Type: research